Product cited in:
Steger, Füller, Garcia-Cuellar et al.: "Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation." in: Leukemia, Vol. 29, Issue 4, pp. 901-8, 2015 (PubMed).
Liu, Chen, zhou et al.: "Insulin-like growth factor-1 and bone morphogenetic protein-2 jointly mediate prostaglandin E2-induced adipogenic differentiation of rat tendon stem cells." in: PLoS ONE, Vol. 9, Issue 1, pp. e85469, 2014 (PubMed).
Nicolas-Francès, Arnauld, Kaminski et al.: "Disturbances in cholesterol, bile acid and glucose metabolism in peroxisomal 3-ketoacylCoA thiolase B deficient mice fed diets containing high or low fat contents." in: Biochimie, Vol. 98, pp. 86-101, 2014 (PubMed).
Moser, Schachtschneider, Lang et al.: "Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis." in: European journal of cancer (Oxford, England : 1990), Vol. 44, Issue 11, pp. 1577-86, 2008 (PubMed).
Sima, Li: "Diabetes and Alzheimer's disease - is there a connection?" in: The review of diabetic studies : RDS, Vol. 3, Issue 4, pp. 161-8, 2007 (PubMed).
Adlerz, Holback, Multhaup et al.: "IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways." in: The Journal of biological chemistry, Vol. 282, Issue 14, pp. 10203-9, 2007 (PubMed).
Butovsky, Koronyo-Hamaoui, Kunis et al.: "Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 31, pp. 11784-9, 2006 (PubMed).
Sandhu: "Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology." in: Endocrine development, Vol. 9, pp. 44-54, 2005 (PubMed).
Remacle-Bonnet, Garrouste, Heller et al.: "Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways." in: Cancer research, Vol. 60, Issue 7, pp. 2007-17, 2000 (PubMed).
Sandberg-Nordqvist, Ståhlbom, Reinecke et al.: "Characterization of insulin-like growth factor 1 in human primary brain tumors." in: Cancer research, Vol. 53, Issue 11, pp. 2475-8, 1993 (PubMed).
Jones, Clemmons: "Insulin-like growth factors and their binding proteins: biological actions." in: Endocrine reviews, Vol. 16, Issue 1, pp. 3-34, 1995 (PubMed).